Jim Omel discusses his participation in the INSIGHT MM & the benefits of real-world evidence with patients participating in trials in multiple myeloma.
INTERVIEWS
INSIGHT MM study – a pharmaceutical company-sponsored study in multiple myeloma
Dawn Marie Stull PharmD., BCOP scientific director and lead of INSIGHT MM at Takeda Oncology, discusses the INSIGHT MM (multiple myeloma) study, the largest pharmaceutical company-sponsored global observational study of its kind in multiple myeloma.
PH10 – Nasal spray that works like spritzers to the brain
Shawn Singh, CEO of VistaGen Therapeutics discusses their pipeline which includes nasal sprays that work like spritzers to the brain, for instance, PH10, an experimental antidepressant that completed a phase 2a study and received a patent and PH94B for Social Anxiety Disorder.
Free Artificial intelligence application to reduce monopoly in healthcare
Dr. Aswini Misro talks about building a free artificial intelligence application to reduce monopoly in healthcare and to educate the patient.
REVIVE – non-caffeinated energy supplement
Dr. Jeff Leighton, a professional pharmacologist, discusses the science behind the newly launched REVIVE, a non-caffeinated energy supplement.
Liver inflammation and damage
Terri Milton discusses the excessive amounts of fat build-up in the liver causing liver inflammation and damage.
VNS therapy for drug resistant epilepsy
Dr. Christi Heck discusses drug-resistant epilepsy and vagus nerve stimulation (VNS) therapy.
First adjuvanted seasonal influenza vaccine for people aged 65 & older
The range of options for children aged six months & older & the first & only adjuvanted seasonal influenza vaccine developed for people aged 65 & older.
The Art of Jin Shin – The Japanese Practice of Healing with Your Fingertips
Alexis Brink, Author of “THE ART OF JIN SHIN: The Japanese Practice of Healing with Your Fingertips”, talks about the practice of Jin Shin, & its benefits.
Mayzent – first & only pill studied & proven in secondary progressive multiple sclerosis (SPMS).
Dr. Regina Berkovich discusses Mayzent, the first and only pill studied and proven in secondary progressive multiple sclerosis (SPMS).